Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 317.06%.
Reported quarterly operating margin; no daily interpolation. Q1 FY2027 (2026-06-30): 0.00%.
OPERATING MARGIN
317.06%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Helus Pharma Inc.
Market Cap
$707.86M
Operating Margin
317.06%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$709.33M
Operating Margin
19.61%
TTM Avg
25.44%
3Y Avg
21.88%
5Y Avg
18.67%
Market Cap
$698.60M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$719.64M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$734.10M
Operating Margin
-4908.21%
TTM Avg
-3903.83%
3Y Avg
-2635.01%
5Y Avg
-1845.37%
Market Cap
$675.41M
Operating Margin
-187.24%
TTM Avg
-253932.81%
3Y Avg
-127981.70%
5Y Avg
-85456.42%
Market Cap
$749.55M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6934.80%
5Y Avg
-9894.67%
Market Cap
$767.46M
Operating Margin
-123601.69%
TTM Avg
-69568.65%
3Y Avg
-35191.57%
5Y Avg
-23714.64%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Helus Pharma Inc. (HELP) | $707.86M | 317.06% | 0.00% | 0.00% | 0.00% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.33M | 19.61% | 25.44% | 21.88% | 18.67% |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $719.64M | 0.00% | 0.00% | 0.00% | 0.00% |
| Annexon, Inc. (ANNX)vs › | $688.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| Anteris Technologies Global Corp. (AVR)vs › | $734.10M | -4908.21% | -3903.83% | -2635.01% | -1845.37% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | -187.24% | -253932.81% | -127981.70% | -85456.42% |
| Candel Therapeutics, Inc. (CADL)vs › | $749.55M | 0.00% | 0.00% | -6934.80% | -9894.67% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $767.46M | -123601.69% | -69568.65% | -35191.57% | -23714.64% |
| Aura Biosciences, Inc. (AURA)vs › | $643.37M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.3%
Operating Margin
317.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-10-31 | 0.00% |
| 2020-06-30 | -488.43% |
| 2019-12-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | 0.00% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
